Literature DB >> 30219208

Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats.

Morgan H James1, Colin M Stopper2, Benjamin A Zimmer2, Nikki E Koll2, Hannah E Bowrey3, Gary Aston-Jones2.   

Abstract

BACKGROUND: The orexin (hypocretin) system is important for reward-driven motivation but has not been implicated in the expression of a multiphenotype addicted state.
METHODS: Rats were assessed for economic demand for cocaine before and after 14 days of short access, long access, or intermittent access (IntA) to cocaine. Rats were also assessed for a number of other DSM-5-relevant addiction criteria following differential access conditions. Orexin system function was assessed by quantification of numbers and activity of orexin cells, pharmacological blockade of the orexin-1 receptor, and subregion-specific knockdown of orexin cell populations.
RESULTS: IntA produced a cluster of addiction-like behaviors that closely recapitulate key diagnostic criteria for addiction to a greater extent than long access or short access. IntA was accompanied by an increase in number and activity of orexin-expressing neurons within the lateral hypothalamic subregion. This increase in orexin cell number and activity persisted during protracted withdrawal from cocaine for at least 150 days and was accompanied by enhanced incubation of craving in the same rats. Selective knockdown of lateral hypothalamic orexin neurons reduced motivation for cocaine, and orexin-1 receptor signaling played a larger role in drug seeking after IntA.
CONCLUSIONS: We provide the first evidence that lateral hypothalamic orexin system function extends beyond general reward seeking to play a critical role in expression of a multiphenotype addiction-like state. Thus, the orexin system is a potential novel target for pharmacotherapies designed to treat cocaine addiction. In addition, these data point to the IntA model as a preferred approach to modeling addiction-like behavior in rats.
Copyright © 2018 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavioral economics; Cocaine; Hypothalamus; Intermittent access; Long access; Plasticity

Mesh:

Substances:

Year:  2018        PMID: 30219208     DOI: 10.1016/j.biopsych.2018.07.022

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  61 in total

1.  Incentive and dopamine sensitization produced by intermittent but not long access cocaine self-administration.

Authors:  Alex B Kawa; Alec C Valenta; Robert T Kennedy; Terry E Robinson
Journal:  Eur J Neurosci       Date:  2019-05-02       Impact factor: 3.386

2.  The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand.

Authors:  Caroline B Pantazis; Morgan H James; Brandon S Bentzley; Gary Aston-Jones
Journal:  Addict Biol       Date:  2019-07-11       Impact factor: 4.280

3.  Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Neuropharmacology       Date:  2019-12-04       Impact factor: 5.250

4.  Embryonic Ethanol Exposure Affects the Early Development, Migration, and Location of Hypocretin/Orexin Neurons in Zebrafish.

Authors:  Adam D Collier; Viktoriya Halkina; Soe S Min; Mia Y Roberts; Samantha D Campbell; Kaylin Camidge; Sarah F Leibowitz
Journal:  Alcohol Clin Exp Res       Date:  2019-07-06       Impact factor: 3.455

5.  Incubation of Cocaine Craving After Intermittent-Access Self-administration: Sex Differences and Estrous Cycle.

Authors:  Céline Nicolas; Trinity I Russell; Anne F Pierce; Steeve Maldera; Amanda Holley; Zhi-Bing You; Margaret M McCarthy; Yavin Shaham; Satoshi Ikemoto
Journal:  Biol Psychiatry       Date:  2019-01-29       Impact factor: 13.382

6.  Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil.

Authors:  Aida Mohammadkhani; Jennifer E Fragale; Caroline B Pantazis; Hannah E Bowrey; Morgan H James; Gary Aston-Jones
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

7.  Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?"

Authors:  Morgan H James; Gary Aston-Jones
Journal:  Brain Res       Date:  2020-01-10       Impact factor: 3.252

8.  Effects of 5-HT2A receptor stimulation on economic demand for fentanyl after intermittent and continuous access self-administration in male rats.

Authors:  David Alexander Martin; Utsav Gyawali; Donna J Calu
Journal:  Addict Biol       Date:  2020-05-26       Impact factor: 4.280

9.  The transition to cocaine addiction: the importance of pharmacokinetics for preclinical models.

Authors:  Alex B Kawa; Florence Allain; Terry E Robinson; Anne-Noël Samaha
Journal:  Psychopharmacology (Berl)       Date:  2019-02-28       Impact factor: 4.530

Review 10.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.